The optimal therapeutic strategy in UICC stage T3 hepatocellular carcinoma (HCC) patients that maximizes both safety and long-term outcome has not yet been determined. Our aim was to compare clinical outcomes following hepatic resection (HR) versus transarterial chemoembolization (TACE) for stage T3 HCC. | Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma A propensity score matching study